Latest filings (excl ownership)
Latest ownership filings
4
Kinnate Biopharma Inc.
5 Apr 24
SC 13G/A
Aclaris Therapeutics, Inc.
13 Feb 24
SC 13G/A
Pharvaris N.V.
13 Feb 24
4
Kinnate Biopharma Inc.
10 May 23
SC 13D/A
Kinnate Biopharma Inc.
10 May 23
SC 13D/A
Kinnate Biopharma Inc.
22 Feb 23
4
Kinnate Biopharma Inc.
22 Feb 23
SC 13G/A
Aclaris Therapeutics, Inc.
13 Feb 23
SC 13G/A
Lyell Immunopharma, Inc.
13 Feb 23
SC 13G/A
Pharvaris N.V.
13 Feb 23
SC 13D/A
Quantum-Si Inc
28 Jun 22
SC 13G/A
Keros Therapeutics, Inc.
11 Feb 22
SC 13G/A
Pharvaris N.V.
11 Feb 22
SC 13G/A
Nurix Therapeutics, Inc.
11 Feb 22
SC 13G
Lyell Immunopharma, Inc.
11 Feb 22
4
James B. Tananbaum
3 Nov 21
SC 13D
Quantum-Si Inc
21 Jun 21
SC 13G/A
Fulcrum Therapeutics, Inc.
16 Feb 21
SC 13G/A
Nurix Therapeutics, Inc.
16 Feb 21
SC 13G/A
Keros Therapeutics, Inc.
16 Feb 21
SC 13G/A
Arbutus Biopharma Corp
16 Feb 21
SC 13G
Pharvaris N.V.
12 Feb 21
3
James B. Tananbaum
10 Feb 21
SC 13D
Kinnate Biopharma Inc.
14 Dec 20
4
Kinnate Biopharma Inc.
9 Dec 20
4
Kinnate Biopharma Inc.
4 Dec 20
3
Kinnate Biopharma Inc.
3 Dec 20
SC 13G
Nurix Therapeutics, Inc.
3 Aug 20
SC 13G
Keros Therapeutics, Inc.
15 Apr 20
4
James B. Tananbaum
2 Mar 20
SC 13G/A
Arbutus Biopharma Corp
14 Feb 20
SC 13G/A
Fulcrum Therapeutics, Inc.
14 Feb 20
SC 13G/A
OptiNose, Inc.
14 Feb 20
SC 13G/A
Turning Point Therapeutics, Inc.
13 Feb 20
4
James B. Tananbaum
23 Dec 19
SC 13G
Arbutus Biopharma Corp
9 Dec 19
4
James B. Tananbaum
5 Dec 19
4
James B. Tananbaum
18 Nov 19
4
James B. Tananbaum
12 Nov 19
3/A
James B. Tananbaum
5 Nov 19